Install Free Gold Price Widget!
Install Free Gold Price Widget!
Install Free Gold Price Widget!
|
- Pfizer: One of the worlds premier biopharmaceutical companies
Pfizer has your back in the fight against cancer With over 50+ programs, 80+ clinical trials worldwide and 40% of our R D budget dedicated to oncology, we're committed to advancements in cancer care
- Newsroom - Pfizer
More than 60 abstracts, including 15 oral and rapid oral presentations, highlight advancements across Pfizer’s industry-leading Oncology portfolio and pipeline Learn more about Pfizer’s presence at the conference here
- Our Science: Pharmaceutical Development - Pfizer
At Pfizer our biotechnology is our foundation With 25,000 clinical researchers testing everyday, pharmaceutical development and innovation are our focus Learn more
- Arvinas and Pfizer Announce Positive Topline Results from Phase 3 . . .
NEW HAVEN, Conn and NEW YORK, March 11, 2025 – Arvinas, Inc (Nasdaq: ARVN) and Pfizer Inc (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial (NCT05654623) evaluating vepdegestrant monotherapy versus fulvestrant in adults with estrogen receptor-positive, human epidermal growth factor receptor 2
- Pfizer’s Core Values of Social Responsibility and Philanthropy
We’re in relentless pursuit of breakthroughs that change patients’ lives We innovate every day to make the world a healthier place It was Charles Pfizer’s vision at the beginning and it holds true today Explore Our Purpose Details
- Pfizer Declares Second-Quarter 2025 Dividend
The second-quarter 2025 cash dividend will be the 346th consecutive quarterly dividend paid by Pfizer About Pfizer: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives
- Coronavirus COVID-19: Vaccine, Drug and Treatment Updates - Pfizer
Pfizer Inc and BioNTech SE today announced that the U S Food and Drug Administration (FDA) has authorized for emergency use a booster dose of the Pfizer-BioNTech COVID-19 Vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe COVID-19, and individuals 18 through 64 years of age whose
- Vaccines - Pfizer
At Pfizer, we have a long history in vaccine research and development, including a pivotal role in the eradication of polio and smallpox Through the development of innovative delivery systems and technologies (the term often used is “novel vaccines”), we’ve created innovations for preventing deadly bacterial infections like those caused
|
|
|